Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Vasopressin antidiuretic agonist and antagonist activity in dogs: structural and stereochemical relationship between bridge and carboxyl terminus.

Albrightson-Winslow CR, Brickson B, Brooks DP, Bryan WM, Caldwell N, Kinter LB, Moore ML, Nambi P, Stassen FL, Huffman WF.

J Pharmacol Exp Ther. 1991 Jan;256(1):335-40.

PMID:
1988664
2.

Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogs.

Albrightson-Winslow CR, Caldwell N, Brooks DP, Huffman WF, Stassen FL, Kinter LB.

J Pharmacol Exp Ther. 1989 May;249(2):366-71.

PMID:
2524585
4.

Solubilization of a guanine nucleotide-sensitive form of vasopressin V2 receptors from porcine kidney.

Aiyar N, Valinski W, Nambi P, Minnich M, Stassen FL, Crooke ST.

Arch Biochem Biophys. 1989 Feb 1;268(2):698-706.

PMID:
2521556
5.

Vasopressin receptor antagonism in rhesus monkey and man: stereochemical requirements.

Brooks DP, Koster PF, Albrightson CR, Huffman WF, Moore ML, Stassen FL, Schmidt DB, Kinter LB.

Eur J Pharmacol. 1989 Jan 24;160(1):159-62.

PMID:
2540987
6.

SK&F 105494: a potent antidiuretic hormone antagonist devoid of partial agonist activity in dogs.

Caldwell N, Brickson B, Kinter LB, Brooks DP, Huffman WF, Stassen FL, Albrightson-Winslow C.

J Pharmacol Exp Ther. 1988 Dec;247(3):897-901.

PMID:
3204522
7.

Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkey.

Brooks DP, Koster PF, Stassen FL, Albrightson CR, Huffman WF, Wasserman MA, Kinter LB.

Br J Pharmacol. 1988 Jul;94(3):759-64.

8.

SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).

Brooks DP, Koster PF, Albrightson-Winslow CR, Stassen FL, Huffman WF, Kinter LB.

J Pharmacol Exp Ther. 1988 Apr;245(1):211-5.

PMID:
3361442
9.

Design, synthesis, and biological activity of a peptide mimic of vasopressin.

Bryan WM, Hempel JC, Huffman WF, Marshall GR, Moore ML, Silvestri J, Stassen FL, Stefankiewicz JS, Sulat L, Webb RL.

J Med Chem. 1988 Apr;31(4):742-4.

PMID:
2965243
10.

Antagonists of the antidiuretic activity of vasopressin.

Kinter LB, Huffman WF, Stassen FL.

Am J Physiol. 1988 Feb;254(2 Pt 2):F165-77. Review.

PMID:
2964201
11.

Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.

Stassen FL, Heckman G, Schmidt D, Papadopoulos MT, Nambi P, Sarau H, Aiyar N, Gellai M, Kinter L.

Mol Pharmacol. 1988 Feb;33(2):218-24.

PMID:
2828915
12.

Potent vasopressin antagonists modified at the carboxy-terminal tripeptide tail.

Ali FE, Chang HL, Huffman WF, Heckman G, Kinter LB, Weidley EF, Edwards R, Schmidt D, Ashton-Shue D, Stassen FL.

J Med Chem. 1987 Dec;30(12):2291-4.

PMID:
2960813
13.

Effects of N-ethylmaleimide on arginine vasopressin-induced responses in an established smooth muscle cell line.

Aiyar N, Nambi P, Stassen FL, Crooke ST.

J Pharmacol Exp Ther. 1987 Jul;242(1):217-21.

PMID:
3112365
14.

Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).

Kinter LB, Churchill S, Stassen FL, Moore M, Huffman W.

J Pharmacol Exp Ther. 1987 Jun;241(3):797-803.

PMID:
3598903
15.

A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.

Stassen FL, Heckman G, Schmidt D, Nambi P, Aiyar N, Landvatter S, Crooke ST.

Mol Pharmacol. 1987 Mar;31(3):267-72.

PMID:
2951585
16.

Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line.

Stassen FL, Heckman G, Schmidt D, Aiyar N, Nambi P, Crooke ST.

Mol Pharmacol. 1987 Mar;31(3):259-66.

PMID:
2951584
17.

Phorbol ester-mediated inhibition of vasopressin and beta-adrenergic responses in a vascular smooth muscle cell line.

Aiyar N, Nambi P, Whitman M, Stassen FL, Crooke ST.

Mol Pharmacol. 1987 Feb;31(2):180-4.

PMID:
3027529
18.

Potent antagonists of vasopressin antidiuretic activity that lack the beta,beta-cyclopentamethylene-beta-mercaptopropionic acid substitution at position 1.

Yim NC, Moore ML, Huffman WF, Bryan HG, Chang HL, Kinter LB, Edwards R, Stassen FL, Schmidt D, Heckman G.

J Med Chem. 1986 Dec;29(12):2425-6. No abstract available.

PMID:
2946863
19.

Induction of functional beta-adrenergic receptors in rat aortic smooth muscle cells by sodium butyrate.

Nambi P, Whitman MH, Schmidt DB, Heckman GD, Stassen FL, Crooke ST.

Biochem Pharmacol. 1986 Nov 1;35(21):3813-20.

PMID:
3022740
20.
21.

Vascular vasopressin receptors mediate inhibition of beta adrenergic receptor-induced cyclic AMP accumulation.

Nambi P, Whitman M, Stassen FL, Crooke ST.

J Pharmacol Exp Ther. 1986 Apr;237(1):143-6.

PMID:
3007735
22.

Desensitization of LLC-PK1 cells by vasopressin results in receptor down-regulation.

Lester BR, Sheppard JR, Burman M, Somkuti SB, Stassen FL.

Mol Cell Endocrinol. 1985 May;40(2-3):193-204.

PMID:
2989032
23.

Antidiuretic hormone antagonists and aquaresis in dogs: different vasopressin sensitivity and antagonist potency in renal cortex and papilla.

Stassen FL, Heckman GD, Huffman WF, Kinter LB.

J Pharmacol Exp Ther. 1985 Jan;232(1):100-5.

PMID:
3965688
24.

Critical differences between species in the in vivo and in vitro renal responses to antidiuretic hormone antagonists.

Stassen FL, Bryan W, Gross M, Kavanagh B, Shue D, Sulat L, Wiebelhaus VD, Yim N, Kinter LB.

Prog Brain Res. 1983;60:395-403. No abstract available.

PMID:
6665152
25.

Molecular mechanisms of novel antidiuretic antagonists: analysis of the effects on vasopressin binding and adenylate cyclase activation in animal and human kidney.

Stassen FL, Erickson RW, Huffman WF, Stefankiewicz J, Sulat L, Wiebelhaus VD.

J Pharmacol Exp Ther. 1982 Oct;223(1):50-4.

PMID:
7120127
26.
27.
28.

Properties of highly purified lysyl oxidase from embryonic chick cartilage.

Stassen FL.

Biochim Biophys Acta. 1976 Jun 7;438(1):49-60.

PMID:
7318
29.

On the mechanism of the increase in prolyl hydroxylase activity in the uterus of the rat given estradiol-17beta.

Salvador RA, Tsai I, Stassen FL.

Biochem Pharmacol. 1976 Apr 15;25(8):907-12. No abstract available.

PMID:
178320
30.

Activation of prolyl hydroxylase in fibroblasts by ascorbic acid.

Cardinale GJ, Stassen FL, Kuttan R, Udenfriend S.

Ann N Y Acad Sci. 1975 Sep 30;258:278-87. No abstract available.

PMID:
173225
31.

Anti-inflammatory steroids and collagen metabolism: glucocorticoid-mediated decrease of prolyl hydroxylase.

Cutroneo KR, Stassen FL, Cardinale GJ.

Mol Pharmacol. 1975 Jan;11(1):44-51. No abstract available.

PMID:
163951
32.

Prolyl hydroxylase and an immunologically related protein in mammalian tissues.

Stassen FL, Cardinale GJ, McGee JO, Udenfriend S.

Arch Biochem Biophys. 1974 Jan;160(1):340-5. No abstract available.

PMID:
4364069
33.

Cell-free synthesis of procollagen: L-929 fibroblasts as a cellular model for dermatosparaxis.

Kerwar SS, Cardinale GJ, Kohn LD, Spears CL, Stassen FL.

Proc Natl Acad Sci U S A. 1973 May;70(5):1378-82.

34.

Activation of prolyl hydroxylase in L-929 fibroblasts by ascorbic acid.

Stassen FL, Cardinale GJ, Udenfriend S.

Proc Natl Acad Sci U S A. 1973 Apr;70(4):1090-3.

35.

Connective tissue reactions to lambda-carrageenan in the rat. Lambda-carrageenan-collagen interaction.

Stassen FL, Kuyper CM.

Exp Mol Pathol. 1972 Apr;16(2):138-46. No abstract available.

PMID:
5014077

Supplemental Content

Loading ...
Support Center